Before he was named one of TIME’s 100 Most Influential and before leading the country’s first uterine transplant trial resulting in a live birth, Giuliano Testa, MD, was a fellow with the Baylor University Medical Center, part of Baylor Scott & White Health, transplant program – a program he now leads.
For more than 30 years, Webb A. Roberts Hospital has loomed over Baylor University Medical Center, part of Baylor Scott & White Health, changing the periphery of the Dallas skyline.
Each year in the United States, approximately 600,000 people have a pulmonary embolism, with an estimated 50,000 to 200,000 dying from the condition. Because of the high mortality rate associated with massive and sub-massive pulmonary embolism, identification and early intervention are critical. Yet, this common condition remains underdiagnosed and undertreated.
In November 2017, a study into the effectiveness of percutaneous coronary intervention (PCI) caught international attention for raising questions about the benefits of angioplasty and stenting. The study, Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA), concluded there was no benefit for patients with stable angina who underwent PCI.
